The subject of the contract is the delivery of medicinal products used in the framework of drug programmes, on the basis laid down in the proposed provisions of the contract in quantities resulting from current needs and within the deadlines of the contract concluded

Mmunoglobulin normal human (IgIV), 10% solution for infusion, vials in different volumes depending on the needs of the Ordering Party. The Contracting Authority requires a medicinal product for use in NFZ drug programs: Treatment of Primary Immunity Deficiency in Children B.17 and Treatment of Immunoglobulins in Neurological Diseases B.67

Immunoglobulin normal human (IgIV), 10% solution for infusion, vials in different volumes depending on the needs of the Ordering Party. The Contracting Authority requires a medicinal product for use in NFZ drug programs: Treatment of primary immunodeficiency in children B.17 and treatment of immunoglobulin translusions in neurological diseases B.67

1. Palivizumabum 100 mg solution for injection x 1 viol.

2. Palivizumabum 50 mg solution for injection x 1 viol.